Susan Desmond-Hellmann MD, MPH ’88 is an oncologist, scientist and philanthropist, who now serves as the CEO of the Bill & Melinda Gates Foundation. Desmond-Hellmann spent 14 years at the biotech firm Genentech developing a number of breakthrough medicines, including two of the first gene-targeted therapies for cancer, Avastin and Herceptin. Her time at Genentech put her at the forefront of the precision medicine revolution, which led to her consideration and appointment to the role of Chancellor of UCSF. With the Gates Foundation, she now leads their efforts to get the right interventions, to the right populations, in the right places, to save lives.


Honoree in the Media:

You might also like:

Maria S. Gomez: Health activist who builds better futures for the DC area’s underserved
Bonnie Duran: Health advocate who combines cultured-centered and evidence-based interventions to create innovative treatments for indigenous communities
Sarah Krevans: Sutter Health President and Chief Executive Officer